Rakuten Aspyrian Announces Appointment of Mickey Mikitani as Chief Executive Officer

20:00 EST 14 Nov 2018 | BioMedReports - Blog

SAN MATEO, Calif., Nov. 14, 2018 /PRNewswire/ -- Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoimmunotherapy platform, today announced

Read more...

More From BioPortfolio on "Rakuten Aspyrian Announces Appointment of Mickey Mikitani as Chief Executive Officer"